Talazoparib/Talazoparib
Talazoparib (unofficial Chinese translation: talazoparib/talazoparib), brand name Talzenna, is an oral poly ADP ribose polymerase (PARP) inhibitor developed by Pfizer for the treatment of advanced breast cancer with germline BRCA…